# Research Peptide FAQ — KPV, MOTS-c, PT-141, Retatrutide, Thymosin Alpha-1 — Peptides Jobs

> Frequently asked questions about five Research Peptide Fundamentals research peptides — KPV, MOTS-c, PT-141, retatrutide, and thymosin alpha-1 — answered from the peer-reviewed literature, with citations.

Direct, citation-anchored answers to the questions most often asked about these five research peptides.

## What is KPV peptide?

KPV is the common short name for a three-amino-acid peptide, lysine-proline-valine, corresponding to the last three residues (the C-terminal end) of a larger natural hormone called alpha-melanocyte-stimulating hormone (alpha-MSH). It retains the parent hormone's anti-inflammatory activity in cell and animal studies without its pigment-darkening (melanogenic) effect [5]. No published human clinical trial of KPV exists, so its human dosing, efficacy, and safety are not established.

## What is KPV peptide used for?

In laboratory and animal research, KPV has been studied almost exclusively for calming intestinal inflammation, most often in mouse models of colitis. Delivery-focused studies have combined it with targeted nanoparticle or hydrogel carriers to keep the small, enzyme-vulnerable peptide intact long enough to reach inflamed gut tissue [1][2]. It is sold only as a laboratory research chemical and has no approved human use.

## What does the MOTS-c peptide do?

MOTS-c is a 16-amino-acid peptide encoded within mitochondrial DNA rather than the cell nucleus. Its best-characterized job is activating AMPK, an enzyme that shifts a cell toward energy-conserving, fat-burning metabolism, primarily in skeletal muscle, and it can also travel to the cell nucleus under metabolic stress to switch on antioxidant-related genes [10]. In mice, it has improved glucose handling and physical-performance measures [9].

## Is MOTS-c legal to buy?

MOTS-c has no FDA-approved use and is sold only as a research chemical intended for laboratory use, not for human consumption. Separately, anti-doping authorities treat MOTS-c as a prohibited peptide in organized sport, so athletes who use it can face sanctions. This page describes research findings only; it is not legal or medical guidance.

## What is PT-141?

PT-141 is the research-chemical name for bremelanotide, a synthetic cyclic peptide that activates melanocortin receptors, chiefly MC4R, concentrated in brain regions that govern sexual desire. Bremelanotide is FDA-approved, by prescription, for acquired, generalized hypoactive sexual desire disorder in premenopausal women [15].

## What is PT-141 used for?

Its approved use is treating hypoactive sexual desire disorder in premenopausal women, based on two Phase 3 trials showing improved desire and reduced desire-related distress over 24 weeks [13]. Use in men or in postmenopausal women is off-label and outside the population the pivotal trials studied.

## What does retatrutide do?

Retatrutide is an investigational peptide that activates three metabolic hormone receptors at once — GLP-1, GIP, and glucagon. Two of those arms reduce appetite and improve insulin release; the third, unique to this molecule, is thought to increase energy expenditure. In a 48-week Phase 2 trial, the highest dose studied produced substantially greater weight loss than placebo [19].

## Is retatrutide FDA approved?

No. Retatrutide is not approved by the FDA or any regulator as of mid-2026; it remains in Phase 3 clinical trials. All published efficacy and safety figures come from Phase 1 and Phase 2 studies, and regulators have taken enforcement action against vendors selling unapproved 'research-grade' retatrutide outside registered trials [16].

## What is thymosin alpha 1?

Thymosin alpha-1 (thymalfasin) is a naturally occurring 28-amino-acid peptide, originally isolated from thymus tissue, whose job is helping immune cells mature and communicate properly. It is approved as a drug in more than 35 countries, though not in the United States [22].

## Is thymosin alpha 1 FDA-approved?

No. Thymosin alpha-1 is not approved for marketing in the United States. It is approved abroad as thymalfasin, and the largest, most rigorous trial to date — a 2025 Phase 3 trial in sepsis involving 1,106 adults — found no significant reduction in mortality, a result that tempers expectations set by smaller, earlier studies [21][22].

## Is Peptides Jobs a job-search or employment site?

No. Despite the name, this is not an employment listing service. 'Jobs' refers to the biological job each peptide performs — the specific task it carries out in the body, such as calming inflammation, activating a metabolic enzyme, or maturing immune cells. This site is an editorial literature review of five research peptides, grouped by the functional role each one plays.

## Are any of these peptides FDA-approved for general use?

Only one, in a narrow sense: bremelanotide (PT-141) is FDA-approved, but solely for hypoactive sexual desire disorder in premenopausal women [15]. Thymosin alpha-1 is approved as a drug in dozens of other countries but not in the United States [22]. Retatrutide is investigational and approved nowhere [16]. KPV and MOTS-c have no approved use in any jurisdiction and are sold only as laboratory research chemicals.

---

This is an editorial literature review of research peptides' biological functions, written for scholarly orientation — not a clinic, not a supplier, and not a substitute for professional medical guidance.